Cargando…

Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers

Cancer is a borderless global health challenge that continues to threaten human health. Studies have found that oxidative stress (OS) is often associated with the etiology of many diseases, especially the aging process and cancer. Involved in the OS reaction as a key transcription factor, Nrf2 is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Li, Wu, Qing, Lu, Feifei, Lei, Jiaming, Zhou, Yanhong, Liu, Yifei, Zhu, Ni, Yu, You, Ning, Zhifeng, She, Tonghui, Hu, Meichun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559910/ https://www.ncbi.nlm.nih.gov/pubmed/37810967 http://dx.doi.org/10.3389/fonc.2023.1184079

Ejemplares similares

ALDH1: A potential therapeutic target for cancer stem cells in solid tumors
por: Wei, Yaolu, et al.
Publicado: (2022)

PELP1 Suppression Inhibits Gastric Cancer Through Downregulation of c-Src-PI3K-ERK Pathway
por: Yan, Hongzhu, et al.
Publicado: (2020)

New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics
por: Thakur, Neha, et al.
Publicado: (2023)

Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma
por: Liao, Rui, et al.
Publicado: (2021)

The status of Nrf2-based therapeutics: current perspectives and future prospects
por: Gazaryan, Irina G., et al.
Publicado: (2016)

CEP55 as a promising biomarker and therapeutic target on gallbladder cancer
por: Huang, Maotuan, et al.
Publicado: (2023)

The Current Role of Adjuvant Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma
por: Su, Lin, et al.
Publicado: (2021)

PCK1 Downregulation Promotes TXNRD1 Expression and Hepatoma Cell Growth via the Nrf2/Keap1 Pathway
por: Tuo, Lin, et al.
Publicado: (2018)

The Therapeutic Potential of Kaemferol and Other Naturally Occurring Polyphenols Might Be Modulated by Nrf2-ARE Signaling Pathway: Current Status and Future Direction
por: Hussain, Yaseen, et al.
Publicado: (2022)

Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
por: Zheng, Yue, et al.
Publicado: (2022)

FNDC5 Causes Resistance to Sorafenib by Activating the PI3K/Akt/Nrf2 Pathway in Hepatocellular Carcinoma Cells
por: Liu, Huayuan, et al.
Publicado: (2022)

Artificial Intelligence for Personalized Medicine in Thyroid Cancer: Current Status and Future Perspectives
por: Li, Ling-Rui, et al.
Publicado: (2021)

The Nrf2 Pathway in Liver Diseases
por: Zhou, Jiaming, et al.
Publicado: (2022)

Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness
por: Espinosa-Sánchez, Asunción, et al.
Publicado: (2020)

Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer
por: Telkoparan-Akillilar, Pelin, et al.
Publicado: (2021)

Agrimol B inhibits colon carcinoma progression by blocking mitochondrial function through the PGC-1α/NRF1/TFAM signaling pathway
por: Xiang, Dongyang, et al.
Publicado: (2022)

Gas6/AXL pathway: immunological landscape and therapeutic potential
por: Zhai, Xiaoqian, et al.
Publicado: (2023)

Genitourinary Oncology: Current Status and Future Challenges
por: Bukowski, Ronald M.
Publicado: (2011)

Radiation Metabolomics: Current Status and Future Directions
por: Menon, Smrithi S., et al.
Publicado: (2016)

Aurora Kinase Inhibitors: Current Status and Outlook
por: Bavetsias, Vassilios, et al.
Publicado: (2015)

Modeling Radioimmune Response—Current Status and Perspectives
por: Friedrich, Thomas, et al.
Publicado: (2021)

Ruptured Hepatocellular Carcinoma: Current Status of Research
por: Xia, Feng, et al.
Publicado: (2022)

Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New Developments
por: Xia, Ruolan, et al.
Publicado: (2021)

Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
por: Himes, Benjamin T., et al.
Publicado: (2021)

Current Status and Future Perspectives on the Etiology of Esophageal Adenocarcinoma
por: Thrift, Aaron P., et al.
Publicado: (2012)

Boron Neutron Capture Therapy: Current Status and Challenges
por: Wang, Song, et al.
Publicado: (2022)

Current status and challenges of immunotherapy in ALK rearranged NSCLC
por: Qi, Rongbin, et al.
Publicado: (2022)

The KEAP1–NRF2 System in Cancer
por: Taguchi, Keiko, et al.
Publicado: (2017)

Molecular Network of Colorectal Cancer and Current Therapeutic Options
por: Huang, Zhe, et al.
Publicado: (2022)

Role of NRF2 in Colorectal Cancer Prevention and Treatment
por: Li, Jiaxiang, et al.
Publicado: (2022)

Angelica Polysaccharide Antagonizes 5-FU-Induced Oxidative Stress Injury to Reduce Apoptosis in the Liver Through Nrf2 Pathway
por: Zeng, Di, et al.
Publicado: (2021)

Transoral Robotic Surgery in the Nordic Countries: Current Status and Perspectives
por: Mäkitie, Antti A., et al.
Publicado: (2018)

Radiomics in Glioblastoma: Current Status and Challenges Facing Clinical Implementation
por: Chaddad, Ahmad, et al.
Publicado: (2019)

Denosumab in Giant Cell Tumor of Bone: Current Status and Pitfalls
por: Li, Hengyuan, et al.
Publicado: (2020)

Current Status of Immune Checkpoint Inhibitor Immunotherapy for Lung Cancer
por: Xiong, Wei, et al.
Publicado: (2021)

Current Status and Prospects of Research on Ischemia-Reperfusion Injury and Ferroptosis
por: Hou, Lin, et al.
Publicado: (2022)

Zanubrutinib for the treatment of lymphoid malignancies: Current status and future directions
por: Wolska-Washer, Anna, et al.
Publicado: (2023)

Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma
por: Padfield, Emily, et al.
Publicado: (2015)

Therapeutic Antibodies for Myeloid Neoplasms—Current Developments and Future Directions
por: Schürch, Christian M.
Publicado: (2018)

Current Landscape: The Mechanism and Therapeutic Impact of Obesity for Breast Cancer
por: Zhao, Chongru, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l40hmggbakdj82cafr5mrg9qou